Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype

Overexpression of p170 glycoprotein, the product of the multiple drug resistance [mdr] gene, has been associated with resistance to various cytotoxic drugs used in the treatment of human neoplasms. Normal renal epithelial cells express p170 as a function of their secretory capacity. Because renal cell carcinomas [RCC] respond poorly to chemotherapeutic regimens, p170 expression was studied in primary RCC. Such expression was measured in 40 human RCC and normal kidney tissues using immunohistochemical staining with the monoclonal antibody C-219. Staining intensities of the whole tumor and of different areas of the cryostat sections were transformed into digital numbers using an algorithm designed for this purpose. In most tumors, an inhomogeneous staining pattern and a correlation between grade of differentiation and C-219 immunoreactivity was observed. A comparison of the tumors according to their histopathologic subtypes showed clear differences. The means [range] of the staining intensities of the different types of RCC: clear cell carcinoma Grade 1 [n = 3], 2.0 [2.0 to 2.0]; clear cell carcinoma Grade 2 [n = 19], 0.8 [0.0 to 2.9]; clear cell carcinoma Grade 3 [n = 5], 0.1 [0.0 to 0.2]; tubular carcinoma [n = 4], 2.0 [2.0 to 3.0]; anaplastic carcinoma [n = 8], 0.05 [0.0 to 0.2]; oncocytoma [n = 1], 0.0 [0.0 to 0.0]; and normal kidney [n = 40], 0.5 [0.0 to 2.0]. The differences between anaplastic, clear cell, and tubular carcinoma were significant [P < 0.001 by Kruskal-Wallis test]. In addition, the difference between the three subgroups of clear cell carcinoma was significant [P < 0.01]. It was concluded that the histopathologic subtypes of RCC correlate with the degree of mdr gene expression, as determined by staining with the C-219 monoclonal antibody.